Pyrexia of unknown origin and pulmonary fibrosis as a presentation of MPO-ANCA associated vasculitis

BMJ Case Reports

Volumn , Issue , 2011, Pages

  Shields, O ^a   Shah, Anand ^a   Mann, B ^a  

^a WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CARBON MONOXIDE; CORTICOSTEROID; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; STEROID;

AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE COUNT; LUNG FIBROSIS; LUNG FUNCTION; MALE; MPO ANCA ASSOCIATED VASCULITIS; PRIORITY JOURNAL; PROGNOSIS; PYREXIA IDIOPATHICA; SPUTUM DISCOLORATION; THORAX RADIOGRAPHY; TREATMENT DURATION; VASCULITIS; WEIGHT REDUCTION;

EID: 79955558939     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.01.2011.3692     Document Type: Article

References (18)

1. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-30. (Pubitemid 29136088)
2. Ando Y, Okada F, Matsumoto S, et al. Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease. CT findings in 51 patients. J Comput Assist Tomogr 2004;28:710-16. (Pubitemid 39195550)
3. Hervier B, Pagnoux C, Agard C, et al. Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis 2009;68:404-7.
4. Akar H, Ozbasli-Levi C, Senturk T, et al. MPO-ANCA-associated small vessel vasculitis presenting as fever of unknown origin. Report of one case. Nephron 2002;92:673-5.
5. Ohnuma K, Hosono O, Katayose T, et al. Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin. Rheumatol Int 2010;30:1651-6.
6. Petersdorf RG. Fever of unknown origin. Ann Intern Med 1969;70:864-6.
7. Efstathiou SP, Pefanis AV, Tsiakou AG, et al. Fever of unknown origin: discrimination between infectious and non-infectious causes. Eur J Intern Med 2010;21:137-43.
8. Jayne D. Review article: Progress of treatment in ANCA-associated vasculitis. Nephrology (Carlton) 2009;14:42-8.
9. Foulon G, Delaval P, Valeyre D, et al. ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med 2008;102:1392-8.
10. Frankel SK, Schwarz MI. Update in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2009;15:463-9.
11. Tzelepis GE, Kokosi M, Tzioufas A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010;36:116-21.
12. Shiraki A, Ando M, Shindoh J, et al. Prevalence of myeloperoxidase- antineutrophil cytoplasmic antibody (MPO-ANCA) in patients with interstitial pneumonia. Nihon Kokyuki Gakkai Zasshi 2007;45:921-6.
13. Csernok E, Lamprecht P, Gross WL. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 2010;22:43-8.
14. Nozu T, Kondo M, Suzuki K, et al. A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration 2009;77:407-15.
15. Eschun GM, Mink SN, Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 2003;123:297-301. (Pubitemid 36126747)
16. Birnbaum J, Danoff S, Askin FB, et al. Microscopic polyangiitis presenting as a 'pulmonary-muscle' syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis? Arthritis Rheum 2007;56:2065-71.
17. Buschman DL, Ballard R. Progressive massive fibrosis associated with idiopathic pulmonary hemosiderosis. Chest 1993;104:293-5. (Pubitemid 23204577)
18. Foucher P, Heeringa P, Petersen AH, et al. Antimyeloperoxidase-associated lung disease. An experimental model. Am J Respir Crit Care Med 1999;160:987-94. (Pubitemid 29442041)